{
    "type": "ETP",
    "ucits": false,
    "replication_method": "physical",
    "leverage": true,
    "derivatives": false,
    "swaps": false,
    "inverse": true,
    "complex_factors": [
        "Leverage",
        "Inverse Exposure",
        "Daily Compounding Effect",
        "Short Exposure",
        "High Risk Rating"
    ],
    "classification": "complex",
    "supporting_data": "The product is a Collateralised Exchange Traded Security (ETP) designed to provide -3x the daily return of the iShares MSCI Taiwan ETF, indicating triple leverage and inverse exposure. The replication method is physical, holding short positions in the underlying ETF stock and cash balances, with no indication of synthetic replication or swap usage. The product explicitly states the presence of daily leverage rebalancing and compounding effects, which can cause returns over periods longer than one day to deviate significantly from the expected -3x multiple, increasing complexity. The risk indicator is 6 out of 7, reflecting a very high risk profile. The product is not UCITS compliant and is intended for sophisticated investors able to monitor positions daily. There is no capital protection, and the product may result in total loss of investment. The absence of derivatives used as an inherent part of the strategy (derivatives are used only for shorting the underlying ETF stock) means 'derivatives' is false, but leverage and inverse exposure mandate classification as complex under MiFID II. The product also carries warnings about the compounding effect, short exposure, and leverage, all of which increase complexity and reduce suitability for retail investors. No swap agreements or total return swaps are mentioned, and the replication is physical, but the leverage and inverse nature, combined with daily rebalancing and compounding, are key complexity drivers."
}